We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAL icon
901
Delta Air Lines
DAL
$58.7B
$11.5M 0.01%
396,599
-24,865
-6% -$948K
SPYV icon
902
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
$11.5M 0.01%
311,974
+29,743
+11% +$1.18M
IOO icon
903
iShares Global 100 ETF
IOO
$9.47B
$11.4M 0.01%
177,892
-2,026
-1% -$141K
WBS icon
904
Webster Financial
WBS
$12.8B
$11.4M 0.01%
269,875
-151,068
-36% -$7.28M
KRE icon
905
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$11.4M 0.01%
195,527
-106,493
-35% -$6.65M
SLYV icon
906
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.04B
$11.3M 0.01%
156,636
+5,667
+4% +$442K
SCD
907
LMP Capital and Income Fund
SCD
$358M
$11.3M 0.01%
919,741
-11,488
-1% -$155K
PCAR icon
908
PACCAR
PCAR
$69.1B
$11.3M 0.01%
206,225
-79,204
-28% -$4.46M
MKSI icon
909
MKS Inc
MKSI
$19.8B
$11.3M 0.01%
110,071
+565
+0.5% +$65.8K
NOG icon
910
Northern Oil and Gas
NOG
$2.5B
$11.3M 0.01%
447,166
+76,570
+21% +$2.22M
MPLX icon
911
MPLX
MPLX
$59.5B
$11.3M 0.01%
387,213
+31,777
+9% +$1.02M
UTHR icon
912
United Therapeutics
UTHR
$22.7B
$11.3M 0.01%
47,869
+12,180
+34% +$2.48M
ENTG icon
913
Entegris
ENTG
$22B
$11.2M 0.01%
121,893
-3,710
-3% -$402K
HACK icon
914
Amplify Cybersecurity ETF
HACK
$3.01B
$11.2M 0.01%
244,967
-105,771
-30% -$5.31M
SPD icon
915
Simplify US Equity PLUS Downside Convexity ETF
SPD
$106M
$11.2M 0.01%
423,788
-59,163
-12% -$1.7M
OGE icon
916
OGE Energy
OGE
$9.54B
$11.2M 0.01%
290,740
+24,625
+9% +$979K
DFP
917
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$429M
$11.2M 0.01%
520,503
-26,303
-5% -$609K
LECO icon
918
Lincoln Electric
LECO
$15.1B
$11.2M 0.01%
90,616
+7,061
+8% +$930K
XSOE icon
919
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.07B
$11.2M 0.01%
389,405
-29,861
-7% -$899K
EFX icon
920
Equifax
EFX
$21.3B
$11.2M 0.01%
61,001
+4,167
+7% +$834K
FSV icon
921
FirstService
FSV
$6.27B
$11.1M 0.01%
91,923
+3,036
+3% +$382K
AQN icon
922
Algonquin Power & Utilities
AQN
$4.36B
$11.1M 0.01%
828,724
+41,701
+5% +$603K
SYNH
923
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$11.1M 0.01%
155,214
+12,915
+9% +$944K
JNPR
924
DELISTED
Juniper Networks
JNPR
$11.1M 0.01%
389,700
-82,046
-17% -$2.59M
HUBB icon
925
Hubbell
HUBB
$26.7B
$11.1M 0.01%
62,030
-6,213
-9% -$1.17M

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.